Captrust Financial Advisors Invests $2.56 Million in UnitedHealth Group Incorporated (UNH) Stock
Captrust Financial Advisors acquired a new position in UnitedHealth Group Incorporated (NYSE:UNH) in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm acquired 13,785 shares of the healthcare conglomerate’s stock, valued at approximately $2,556,000.
Several other institutional investors and hedge funds have also recently added to or reduced their stakes in UNH. Arxis Securities LLC purchased a new position in shares of UnitedHealth Group in the 1st quarter valued at approximately $532,000. Pioneer Investment Management Inc. lifted its stake in shares of UnitedHealth Group by 50.8% in the 1st quarter. Pioneer Investment Management Inc. now owns 1,185,327 shares of the healthcare conglomerate’s stock valued at $194,405,000 after purchasing an additional 399,133 shares during the period. Jaffetilchin Investment Partners LLC lifted its stake in shares of UnitedHealth Group by 16.3% in the 1st quarter. Jaffetilchin Investment Partners LLC now owns 6,330 shares of the healthcare conglomerate’s stock valued at $1,038,000 after purchasing an additional 889 shares during the period. Zweig DiMenna Associates LLC lifted its stake in shares of UnitedHealth Group by 35.0% in the 1st quarter. Zweig DiMenna Associates LLC now owns 80,631 shares of the healthcare conglomerate’s stock valued at $13,224,000 after purchasing an additional 20,900 shares during the period. Finally, CIBC World Markets Inc. lifted its stake in shares of UnitedHealth Group by 388.5% in the 1st quarter. CIBC World Markets Inc. now owns 513,936 shares of the healthcare conglomerate’s stock valued at $84,291,000 after purchasing an additional 408,737 shares during the period. Institutional investors own 85.71% of the company’s stock.
In related news, Director Kenneth Irwin Shine sold 457 shares of UnitedHealth Group stock in a transaction on Tuesday, November 14th. The stock was sold at an average price of $211.03, for a total transaction of $96,440.71. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Gail R. Wilensky sold 5,600 shares of UnitedHealth Group stock in a transaction on Tuesday, September 5th. The shares were sold at an average price of $199.49, for a total value of $1,117,144.00. Following the transaction, the director now owns 60,834 shares in the company, valued at $12,135,774.66. The disclosure for this sale can be found here. Insiders sold 57,606 shares of company stock valued at $11,433,133 in the last ninety days. 0.89% of the stock is currently owned by corporate insiders.
Shares of UnitedHealth Group Incorporated (UNH) opened at $210.25 on Tuesday. The company has a quick ratio of 0.70, a current ratio of 0.70 and a debt-to-equity ratio of 0.52. UnitedHealth Group Incorporated has a fifty-two week low of $148.56 and a fifty-two week high of $213.93. The company has a market capitalization of $202,880.00, a price-to-earnings ratio of 21.86, a P/E/G ratio of 1.56 and a beta of 0.64.
UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, October 17th. The healthcare conglomerate reported $2.66 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $2.57 by $0.09. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.50%. The company had revenue of $50.32 billion during the quarter, compared to analyst estimates of $50.38 billion. During the same quarter in the previous year, the company posted $2.17 earnings per share. UnitedHealth Group’s revenue was up 8.7% compared to the same quarter last year. analysts forecast that UnitedHealth Group Incorporated will post 9.99 EPS for the current fiscal year.
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 12th. Investors of record on Friday, December 1st will be issued a $0.75 dividend. This represents a $3.00 annualized dividend and a dividend yield of 1.43%. The ex-dividend date is Thursday, November 30th. UnitedHealth Group’s payout ratio is currently 34.09%.
A number of research analysts have recently commented on UNH shares. Zacks Investment Research cut UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Tuesday, October 10th. ValuEngine lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Thursday, October 5th. Cantor Fitzgerald reaffirmed a “buy” rating and set a $208.00 price objective on shares of UnitedHealth Group in a research report on Tuesday, October 17th. Piper Jaffray Companies raised their price objective on UnitedHealth Group to $228.00 and gave the company an “overweight” rating in a research report on Tuesday, October 17th. Finally, Morgan Stanley raised their price objective on UnitedHealth Group from $210.00 to $215.00 and gave the company an “overweight” rating in a research report on Thursday, August 17th. Three equities research analysts have rated the stock with a hold rating and twenty-four have issued a buy rating to the stock. UnitedHealth Group currently has an average rating of “Buy” and a consensus price target of $216.65.
UnitedHealth Group Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with Analyst Ratings Network's FREE daily email newsletter.